A comparison of risk factors for mortality from heart failure in Asian and non-Asian populations: An overview of individual participant data from 32 prospective cohorts from the Asia-Pacific Region

BMC Cardiovascular Disorders

Mark Woodward⁶  Xianghua Fang³  Sun Ha Jee^1,10  Takayoshi Ohkubo⁸  Suma Konety⁹  Kazem Rahimi⁵  Tai Hing Lam¹  Graham Giles⁷  Jean Woo⁴  Federica Barzi⁶  Rachel R Huxley² 

[1] School of Public Health/Department of Community Medicine, The University of Hong Kong, Hong Kong, China;Epidemiology & Biostatistics Division, School of Population Health, University of Queensland, Brisbane, Australia;Department of Epidemiology and Social Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China;Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China;Department of Cardiovascular Medicine, University of Oxford, Oxford, UK;The George Institute for Global Health, University of Sydney, Sydney, Australia;Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia;Department of Health Science, Shiga University of Medical Science, Shiga, Japan;Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA;Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea

关键词: Epidemiology;    Heart failure;    Meta-analysis;   

Others  :  855083
DOI  :  10.1186/1471-2261-14-61

 received in 2013-11-18, accepted in 2014-04-23,  发布年份 2014

【 摘 要 】

Background

Most of what is known regarding the epidemiology of mortality from heart failure (HF) comes from studies within Western populations with few data available from the Asia-Pacific region where the burden of heart failure is increasing.

Methods

Individual level data from 543694 (85% Asian; 36% female) participants from 32 cohorts in the Asia Pacific Cohort Studies Collaboration were included in the analysis. Adjusted hazard ratios (HR) and 95% confidence intervals (CI) for mortality from HF were estimated separately for Asians and non-Asians for a quintet of cardiovascular risk factors: systolic blood pressure, diabetes, body mass index, cigarette smoking and total cholesterol. All analyses were stratified by sex and study.

Results

During 3,793,229 person years of follow-up there were 614 HF deaths (80% Asian). The positive associations between elevated blood pressure, obesity, and cigarette smoking were consistent for Asians and non-Asians. There was evidence to indicate that diabetes was a weaker risk factor for death from HF for Asians compared with non-Asians: HR 1.26 (95% CI: 0.74-2.13) versus 3.04 (95% CI 1.76-5.25) respectively; p for interaction = 0.022. Additional adjustment for covariates did not materially change the overall associations. There was no good evidence to indicate that total cholesterol was a risk factor for HF mortality in either population.

Conclusions

Most traditional cardiovascular risk factors including elevated blood pressure, obesity and cigarette smoking appear to operate similarly to increase the risk of death from HF in Asians and non-Asians populations alike.

【 授权许可】

   
2014 Huxley et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]McMurray JJ, Pfeffer MA: Heart failure. Lancet 2005, 365:1877-1889.
• [2]Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171. doi:10.1161/CIRCULATIONAHA.106.179918. Accessed September 10, 2013
• [3]Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, et al.: Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220. doi:10.1161/CIR.0b013e31823ac046. Accessed September 10, 2013
• [4]McMurray JJ, Petrie MC, Murdoch DR, Davie AP: Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 1998, 19(Suppl P):P9.
• [5]Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE: The epidemiology of heart failure. Eur Heart J 1997, 18:208-225.
• [6]Hoes AW, Mosterd A, Grobbee DE: An epidemic of heart failure? Recent evidence from Europe. Eur Heart J 1998, 19(Suppl L):L2.
• [7]Ng TP, Niti M: Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998. Heart 2003, 89:865-870.
• [8]Sanderson JE: Heart failure; a growing epidemic in Asia. Hong Kong Med J 2004, 10:76.
• [9]Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, Wang TJ, Larson MG, Levy D, Vasan RS, Massaro JM, Beiser A, Wolf PA, Benjamin EJ, Framingham Heart Study: Lifetime risks for developing congestive heart failure: the Framingham Heart Study. Circulation 2002, 106:3068-3072.
• [10]Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH: Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004, 25:1614-1619.
• [11]Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, Narula J, Shor ES, Young JB, Hong Y, American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; Functional Genomics and Translational Biology Interdisciplinary Working Group: Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117:2544-2565.
• [12]He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK: Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001, 161:996-1002.
• [13]Huxley RR, Barzi F, Lam TH, Czernichow S, Fang X, Welborn T, Shaw J, Ueshima H, Zimmet P, Jee SH, Patel JV, Caterson I, Perkovic V, Woodward M, Asia Pacific Cohort Studies Collaboration and the Obesity in Asia Collaboration: Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation 2011, 124:2056-2064.
• [14]Asia Pacific Cohort Studies Collaboration: Determinants of Cardiovascular Disease in the Asian Pacific Region: Protocol for a Collaborative Overview of Cohort Studies. CVD Prev 1999, 2:281-289.
• [15]Woodward M, Barzi F, Martiniuk A, Fang X, Gu DF, Imai Y, Lam TH, Pan WH, Rodgers A, Suh I, Jee SH, Ueshima H, Huxley R, Asia Pacific Cohort Studies Collaboration: Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol 2006, 35:1412-1416.
• [16]Asia Pacific Cohort Studies Collaboration: Blood pressure and cardiovascular disease in the Asia Pacific Region. J Hypertens 2003, 21:707-716.
• [17]Asia Pacific Cohort Studies Collaboration: Cholesterol, coronary heart disease and stroke in the Asia Pacific region. Int J Epidemiol 2003, 32:563-572.
• [18]Asia Pacific Cohort Studies Collaboration: Body mass index and cardiovascular disease in the Asia Pacific Region: An overview of 33 cohorts involving 310,000 participants. Int J Epidemiol 2004, 31:1025-1033.
• [19]Asia Pacific Cohort Studies Collaboration: The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific Region. Diabetes Care 2003, 26:360-366.
• [20]Asia Pacific Cohort Studies Collaboration: Smoking, quitting and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol 2005, 34:1036-1045.
• [21]WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
• [22]Woodward M: Epidemiology: Study design and data analysis. 2nd edition. Boca Raton: Chapman and Hall/CRC Press; 2005.
• [23]MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
• [24]Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK: The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557-1562.
• [25]Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34.
• [26]Yip GWK, Ho PPY, Woo KS, Sanderson JE: Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong. Am J Cardiol 1999, 84:563-567.
• [27]Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB: The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 2004, 27:1879-1884.
• [28]Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG: Predictors of Heart Failure Among Women With Coronary Disease. Circulation 2004, 110:1424-1430.
• [29]Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005, 165:55-61.
• [30]Anker SD, Sharma R: The syndrome of cardiac cachexia. Int J Cardiol 2002, 85:51-66.
• [31]Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001, 103:2055-2059.
• [32]Aquilani R, Opasich C, Verri M, Boschi F, Febo O, Pasini E, Pastoris O: Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 2003, 42:1218-1223.
• [33]Freeman LM, Roubenoff R: The nutrition implications of cardiac cachexia. Nutr Rev 1994, 52:340-347.
• [34]Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, Clark AL, Anker SD: Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003, 9:29-35.
• [35]Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the Risk of Heart Failure. N Engl J Med 2002, 347:305-313.
• [36]Velagaleti RS, Massaro J, Vasan RS, Robins SJ, Kannel WB, Levy D: Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study. Circulation 2009, 120:2345-2351.
• [37]Nago N, Ishikawa S, Goto T, Kayaba K: Low cholesterol is associated with mortality from stroke, heart disease and cancer: The Jichi Medical School Cohort Study. J Epidemiol 2011, 21:67-74.
• [38]Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, CORONA Group: Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007, 357:2248-2261.
• [39]Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G, Gissi-HF Investigators: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1231-1239.
• [40]Cholesterol Treatment Trialists’ (CTT) Collaboration: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010, 376:1670-1681.
• [41]Ma E, Iso H, Takahashi H, Yamagishi K, Tanigawa T: Age-Period-Cohort analysis of mortality due to ischemic heart disease in Japan, 1955 to 2000. Circ J 2008, 72:966-972.
• [42]Barac A, Wang H, Shara NM, de Simone G, Carter EA, Umans JG, Best LG, Yeh J, Dixon DB, Devereux RB, Howard BV, Panza JA: Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study. J Clin Hypertens 2012, 14:13-19.
• [43]Butler J, Kalogeropoulos A, Georgiopoulou V, Belue R, Rodondi N, Garcia M, Bauer DC, Satterfield S, Smith AL, Vaccarino V, Newman AB, Harris TB, Wilson PW, Kritchevsky SB, Health ABC Study: Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail 2008, 1:125-133.